- Início
- Euronext Bruxelas
- Company regulated news
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
28 Oct 2022 17:40 CEST |
NEXTENSA | Nextensa SA: REInvest achète le bâtiment Bronze Gate | 35102030 Office REITs | Commercial operations |
28 Oct 2022 08:45 CEST |
TEXAF | TEXAF ONTVANGT CONGO BIENNALE | 35101010 Real Estate Holding and Development | Other subject |
28 Oct 2022 08:45 CEST |
TEXAF | TEXAF IS HOSTING CONGO BIENNALE | 35101010 Real Estate Holding and Development | Other subject |
28 Oct 2022 08:45 CEST |
TEXAF | TEXAF ACCUEILLE LA CONGO BIENNALE | 35101010 Real Estate Holding and Development | Other subject |
28 Oct 2022 08:15 CEST |
BEKAERT | Bekaert - Mise à jour relative au Programme de Rachat d’Actions et au Contrat de Liquidité | 55102010 Iron and Steel | Legal |
28 Oct 2022 08:15 CEST |
BEKAERT | Bekaert - Update over het Inkoop van Eigen Aandelen Programma en de Liquiditeitsovereenkomst | 55102010 Iron and Steel | Legal |
28 Oct 2022 08:15 CEST |
BEKAERT | Bekaert - Update on the Share Buyback Program and the Liquidity Agreement | 55102010 Iron and Steel | Legal |
28 Oct 2022 07:01 CEST |
BIOCARTIS | Press release Biocartis Group NV: Biocartis Announces Conversion of a Portion of the Convertible Term Loan into New Shares and Discloses Outstanding Voting Securities | 20101025 Health Services | Change in Capital |
28 Oct 2022 07:01 CEST |
BIOCARTIS | Persbericht Biocartis Group NV: Biocartis kondigt conversie aan van een deel van de converteerbare termijnlening in Nieuwe Aandelen en maakt uitstaande stemrechtverlenende effecten openbaar | 20101025 Health Services | Change in Capital |
28 Oct 2022 07:00 CEST |
BIOCARTIS | Press release Biocartis Group NV: Invitation to the Extraordinary Shareholders’ Meeting | 20101025 Health Services | General meeting / Board Meeting |
28 Oct 2022 07:00 CEST |
BIOCARTIS | Persbericht Biocartis Group NV: Oproeping tot de Buitengewone Algemene Aandeelhoudersvergadering | 20101025 Health Services | General meeting / Board Meeting |
28 Oct 2022 06:59 CEST |
RECTICEL | Recticel Trading update third quarter 2022 | 50203015 Plastics | Other subject |
28 Oct 2022 06:59 CEST |
RECTICEL | Recticel activiteitenverslag derde kwartaal 2022 | 50203015 Plastics | Other subject |
27 Oct 2022 22:00 CEST |
MDXHEALTH | MDxHealth Reports Q3-2022 Results | 20103010 Biotechnology | Commercial results |
27 Oct 2022 22:00 CEST |
MDXHEALTH | MDxHealth communique ses résultats du 3e trimestre de l’exercice 2022 | 20103010 Biotechnology | Commercial results |
27 Oct 2022 18:00 CEST |
EXMAR ord. | Resultaten derde kwartaal 2023 | 50206030 Marine Transportation | Corporate life |
27 Oct 2022 17:58 CEST |
EXMAR ord. | Third quarter results 2022 | 50206030 Marine Transportation | Corporate life |
27 Oct 2022 17:40 CEST |
BIOCARTIS | Persbericht Biocartis Group NV: Resultaten van de Buitengewone Algemene Aandeelhoudersvergadering gehouden op 27 oktober 2022 | 20101025 Health Services | General meeting / Board Meeting |
27 Oct 2022 17:40 CEST |
BIOCARTIS | Press release Biocartis Group NV: Results of the Extraordinary Shareholders’ Meeting held on 27 October 2022 | 20101025 Health Services | General meeting / Board Meeting |
27 Oct 2022 16:51 CEST |
SHURGARD | 20221026 Shurgard opens new self-storage property in Paris Region Sartrouville | 35101010 Real Estate Holding and Development | Other subject |
27 Oct 2022 08:05 CEST |
BELYSSE GROUP NV | Wijziging in de Raad van Bestuur | 40202015 Household Furnishings | Other subject |
27 Oct 2022 08:04 CEST |
BELYSSE GROUP NV | Change in Board of Directors | 40202015 Household Furnishings | Other subject |
27 Oct 2022 07:01 CEST |
BELYSSE GROUP NV | Belysse Group nv Q3 2022 Resultaten | 40202015 Household Furnishings | Other subject |
27 Oct 2022 07:00 CEST |
KINEPOLIS GROUP | Business update derde kwartaal 2022 | 40301010 Entertainment | Commercial results |
27 Oct 2022 07:00 CEST |
KINEPOLIS GROUP | Business update third quarter 2022 | 40301010 Entertainment | Commercial results |
27 Oct 2022 07:00 CEST |
ARGENX SE | argenx Reports Third Quarter 2022 Financial Results and Provides Business Update | 20103010 Biotechnology | Other subject |
27 Oct 2022 07:00 CEST |
KINEPOLIS GROUP | Business update troisième trimestre 2022 | 40301010 Entertainment | Commercial results |
27 Oct 2022 06:59 CEST |
BELYSSE GROUP NV | Belysse Group nv Q3 2022 Results | 40202015 Household Furnishings | Other subject |
26 Oct 2022 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
26 Oct 2022 18:00 CEST |
VAN DE VELDE | VAN DE VELDE : Acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
26 Oct 2022 17:43 CEST |
CRESCENT | GEREGLEMENTEERDE INFORMATIE - Crescent bevestigt benoeming van KPMG als commissaris | 15101010 Telecommunications Equipment | Other subject |
26 Oct 2022 17:41 CEST |
CRESCENT | REGULATED INFORMATION - Crescent confirms appointment of KPMG as auditor | 15101010 Telecommunications Equipment | Other subject |
26 Oct 2022 08:15 CEST |
AGEAS | Marchés financiers défavorables en Chine et l’impact important de l’inflation au Royaume-Uni et en Turquie affectent le résultat net d'Ageas du 3ème trimestre 2022. L’engagement de dividende maintenu. | 30301010 Life Insurance | Other financial transaction |
26 Oct 2022 08:15 CEST |
AGEAS | Ongunstige financiële markten in China en de sterke impact van inflatie in het VK en Turkije beïnvloeden nettoresultaat van Ageas voor het derde kwartaal van 2022. Dividendtoezegging gehandhaafd. | 30301010 Life Insurance | Other financial transaction |
26 Oct 2022 08:15 CEST |
AGEAS | Adverse financial markets in China and the strong impact of inflation in the UK and Türkiye affect Ageas’s Q3 2022 net result. Dividend commitment maintained. | 30301010 Life Insurance | Other financial transaction |
26 Oct 2022 07:00 CEST |
MELEXIS | Melexis Q3 2022 resultaten – Omzet van 219.8 miljoen EUR in het derde kwartaal | 10102010 Semiconductors | Corporate life |
26 Oct 2022 07:00 CEST |
MELEXIS | Melexis Q3 2022 results – Third quarter sales of 219.8 million EUR | 10102010 Semiconductors | Corporate life |
26 Oct 2022 07:00 CEST |
MELEXIS | Melexis Q3 2022 résultats – Chiffre d'affaires de 219.8 millions d'euros au troisième trimestre | 10102010 Semiconductors | Corporate life |
25 Oct 2022 18:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 September 2022 | 35102045 Retail REITs | New |
25 Oct 2022 18:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 septembre 2022 | 35102045 Retail REITs | New |
25 Oct 2022 18:00 CEST |
WERELDHAVE BELGIUM | Trading update 30 september 2022 | 35102045 Retail REITs | New |
25 Oct 2022 17:46 CEST |
BALTA GROUP | Transparantieverklaring UBS GROUP AG | 40202015 Household Furnishings | Other subject |
25 Oct 2022 17:45 CEST |
BALTA GROUP | Transparency Notification UBS GROUP AG | 40202015 Household Furnishings | Other subject |
25 Oct 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 17/10/2022 au 21/10/2022 | 30202010 Asset Managers and Custodians | Other subject |
25 Oct 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 17/10/2022 tot 21/10/2022 | 30202010 Asset Managers and Custodians | Other subject |
25 Oct 2022 08:30 CEST |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 17/10/2022 to 21/10/2022 | 30202010 Asset Managers and Custodians | Other subject |
25 Oct 2022 08:00 CEST |
BEFIMMO | Befimmo NV: Heropening van het Bod als vereenvoudigde squeeze-out | 35102030 Office REITs | Takeover bids |
25 Oct 2022 08:00 CEST |
BEFIMMO | Befimmo SA: Reopening of the Offer as a simplified squeeze-out | 35102030 Office REITs | Takeover bids |
25 Oct 2022 08:00 CEST |
BEFIMMO | Befimmo SA: Réouverture de l’Offre sous la forme d’un squeeze-out simplifié | 35102030 Office REITs | Takeover bids |
25 Oct 2022 07:00 CEST |
BONE THERAPEUTICS | Bone Therapeutics entame une nouvelle histoire sur Euronext et change de nom pour devenir BioSenic, suite à l'acquisition d'une participation majoritaire à hauteur de 40 M€ dans Medsenic | 20103010 Biotechnology | Mergers, Acquiqitions, Transferts |